The article discusses the FDA's process for allowing tobacco companies to market products with claims of reduced risk. It explores how the placement of these claims in advertising can influence consumer perceptions and behaviors.
Understanding these regulations is crucial for public health efforts to reduce tobacco-related harm and inform policy decisions regarding tobacco marketing practices.